Advances in the treatment of liver tumors.
Curley
Steven A
SA
The University of Texas M.D. Anderson Cancer Center, Houston, USA.
Cusack
James C
JC
Tanabe
Kenneth K
KK
Stoelzing
Oliver
O
Ellis
Lee M
LM
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001918:Brachytherapy / Q000379:methods; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods; D003110:Colonic Neoplasms / Q000556:secondary; D003131:Combined Modality Therapy; D003972:Diathermy / Q000379:methods; D004621:Embolization, Therapeutic; D006498:Hepatectomy; D006801:Humans; D008099:Liver / Q000502:physiology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000628:therapy; D011169:Portal Vein / Q000601:surgery; D014780:Viruses / Q000235:genetics / Q000276:immunology
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents